Thus, understanding the mechanisms that regulate NKG2DL expression on stressed melanocytes can lead to development of therapeutic approaches targeting the interactions of NKG2D+ self-reactive CD8 T cells with melanocytes in vitiligo. The gene discussed is KLRK1; the disease is vitiligo.